newdrugapprovals.org
Posizolid in phase 2 for tuberculosis
POSIZOLID 252260-02-9 CAS NO (5R)-3-[4-[1-[(2S)-2,3-Dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one AstraZeneca (Originator) …